(Q38117908)

English

Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis

scientific article published on 28 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 August 2017

Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis (English)

1 reference

Europe PubMed Central

29 August 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

29 August 2017

Sharon E Straus

9

object named as

Sharon E Straus

0 references

object named as

Brian Hutton

6

0 references

Andrea C. Tricco

1

object named as

Andrea C Tricco

1 reference

Europe PubMed Central

29 August 2017

Charlene Soobiah

3

object named as

Charlene Soobiah

1 reference

Europe PubMed Central

29 August 2017

2

object named as

Jesmin Antony

1 reference

Europe PubMed Central

29 August 2017

Sumit Ranjan Majumdar

8

object named as

Sumit R Majumdar

1 reference

Europe PubMed Central

29 August 2017

author name string

Brenda Hemmelgarn

4

1 reference

Europe PubMed Central

29 August 2017

Catherine H Yu

7

1 reference

Europe PubMed Central

29 August 2017

publication date

28 June 2013

1 reference

Europe PubMed Central

29 August 2017

Systematic Reviews

1 reference

Europe PubMed Central

29 August 2017

2

1 reference

Europe PubMed Central

29 August 2017

47

1 reference

Europe PubMed Central

29 August 2017

https://scigraph.springernature.com/pub.10.1186/2046-4053-2-47

0 references

Diagnosis and classification of diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

Assessing the sensitivity of meta-analysis to selection bias: a multiple imputation approach.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

Checking consistency in mixed treatment comparison meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

An evidence-based practice guideline for the peer review of electronic search strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

Overstating the evidence: double counting in meta-analysis and related problems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

Combination of direct and indirect evidence in mixed treatment comparisons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

Popping the (PICO) question in research and evidence-based practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

Quantifying heterogeneity in a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

Meta-analysis in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

The Measurement of Observer Agreement for Categorical Data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

6 September 2017

Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3702520

31 August 2018

Inference from Iterative Simulation Using Multiple Sequences

1 reference

https://api.crossref.org/works/10.1186%2F2046-4053-2-47

21 January 2018

Systematic Reviews and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1186%2F2046-4053-2-47

21 January 2018

Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care

1 reference

https://pubmed.ncbi.nlm.nih.gov/23810103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/2046-4053-2-47

1 reference

Europe PubMed Central

29 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

29 August 2017

1 reference

Europe PubMed Central

29 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38117908&oldid=1744864443"